Lista articolelor în limba engleza
Afisarea articolelor: 1-1(1)
2018
1. | A CCR2/5 inhibitor, PF-04634817, is inferior to monthly ranibizumab in the treatment of diabetic macular edema . Investigative Ophthalmology and Visual Science. 2018, nr. 6(59), 2669-2659. ISSN 0146-0404. (Cat. ) |
1-1 of 1